Autologous Tumor Membrane Vesicles Vaccine(Emory University)

N/A

Report date: 2025/03/12 20:00:47

Base Information

Drug NameAutologous Tumor Membrane Vesicles Vaccine(Emory University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsParanasal Sinus DiseasesOropharyngeal NeoplasmsHypopharyngeal Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesEmory University
Inactive CompaniesN/A
Active IndicationsParanasal Sinus DiseasesOropharyngeal NeoplasmsHypopharyngeal Neoplasms +[8] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A